Tesla (TSLA) Stock Climbs Friday Amid Investor Concerns Over $25B Capex Plan

Key Takeaways

• TSLA shares climbed 2.7% in April, marking the first monthly advance in 2026, yet the stock trails 15% below year-end 2025 levels
• Shares command a lofty valuation near 180 times projected forward earnings, justified only if ambitious AI initiatives deliver results
• The robotaxi program now operates in Dallas, Houston, and San Francisco alongside Austin, falling drastically short of Musk’s multi-city vision
• Capital expenditure is projected to hit $25 billion in 2026, a dramatic jump from the previous year’s sub-$9 billion level, with analysts forecasting $9 billion in negative cash flow
• April vehicle registrations surged across Europe, including triple-digit percentage gains in France and Denmark

Tesla shares were changing hands at $386.69 during Friday trading, posting a 1.2% intraday advance as the market weighed sluggish artificial intelligence deployment against improving European demand trends.

Tesla, Inc., TSLA

The session’s uptick follows April’s 2.7% monthly climb — representing the company’s sole positive month so far in 2026. Prior to April, TSLA shares declined across 13 of the preceding 17 weekly periods. Year-to-date performance remains negative at 15%.

Valuation metrics reveal the underlying tension. The automaker currently commands approximately 180 times forward earnings estimates. Such a premium pricing multiple requires investors to embrace the premise that AI-driven initiatives will materialize as planned. Through the opening third of 2026, evidence of that transformation remains elusive.

Tesla initiated its autonomous ride-hailing offering in Austin, Texas last June with a limited vehicle fleet and mandatory human safety operators seated alongside passengers. The service footprint has subsequently grown to include San Francisco, Dallas, and Houston.

While expansion into four markets represents forward movement, CEO Elon Musk has publicly articulated ambitions for deployment across dozens of metropolitan areas reaching half of America’s population. Measured against that benchmark, the company’s current footprint represents a significant shortfall.

Robotics Development Remains Opaque

Regarding the humanoid robotics program, Tesla elected not to demonstrate the newest iteration of its Optimus platform during the first quarter earnings presentation, attributing the decision to competitive strategy considerations. The omission disappointed shareholders seeking tangible evidence of technological advancement.

Musk has characterized humanoid robots as potentially the most significant commercial product in civilization’s history. Without public demonstrations of the latest generation hardware, assessing the program’s actual development stage proves challenging.

The capital allocation strategy introduces additional investor apprehension. Tesla management has outlined a $25 billion capital expenditure target for 2026, representing nearly a threefold increase from 2025’s figure below $9 billion. Financial analysts project approximately $9 billion in cash consumption for the current year, a stark contrast to the $6 billion in positive free cash flow the company produced during 2025.

This represents a dramatic financial trajectory shift, with shareholders effectively financing an AI transformation whose timeline to profitability remains unclear.

Continental Sales Momentum Builds

Not all operational indicators point negative. Tesla’s European performance data revealed substantial April improvement.

Vehicle registrations jumped 112% year-over-year in France, 102% in Denmark, and 23% in the Netherlands. Examining the full first quarter, European deliveries increased nearly 45% compared to the prior-year period.

This resurgence follows consecutive annual European sales contractions, including 2025’s 27% decline.

Elevated petroleum prices stemming from Iran-related geopolitical tensions appear to be stimulating electric vehicle adoption throughout the region. Additionally, Tesla secured regulatory authorization in the Netherlands for its advanced driver assistance technology, with Dutch regulators informing the European Commission of intentions to pursue continent-wide approval.

The competitive environment remains challenging. BYD alongside other Chinese manufacturers continue expanding European market share. Tesla’s product portfolio is also aging — the Model Y, its most recent volume offering, debuted in 2020.

Tesla’s latest quoted price Friday stood at $386.69, representing an approximate 1.2% session gain.

The post Tesla (TSLA) Stock Climbs Friday Amid Investor Concerns Over $25B Capex Plan appeared first on Blockonomi.